Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) has a cash flow conversion efficiency ratio of -0.001x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-143.88K) by net assets ($194.79 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share - Cash Flow Conversion Efficiency Trend (2024–2025)
This chart illustrates how Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Oaktree Acquisition Corp. III Life Scien debt and liabilities for a breakdown of total debt and financial obligations.
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Solvar Ltd
AU:SVR
|
0.099x |
|
Monument Mining Limited
V:MMY
|
0.113x |
|
Honghua Group Limited
F:4HB
|
0.011x |
|
Thayer Ventures Acquisition Corporation II Class A Ordinary Shares
NASDAQ:TVAI
|
0.000x |
|
Akwel SA
PA:AKW
|
0.048x |
|
Simplex Infrastructures Limited
NSE:SIMPLEXINF
|
0.222x |
|
Nilkamal Limited
NSE:NILKAMAL
|
0.022x |
|
Utah Medical Products Inc
NASDAQ:UTMD
|
0.033x |
Annual Cash Flow Conversion Efficiency for Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (2024–2025)
The table below shows the annual cash flow conversion efficiency of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share from 2024 to 2025. For the full company profile with market capitalisation and key ratios, see Oaktree Acquisition Corp. III Life Scien market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $194.79 Million | $-422.08K | -0.002x | -353.00% |
| 2024-12-31 | $187.50 Million | $-89.69K | 0.000x | -- |
About Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in … Read more